Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR · Real-Time Price · USD
88.70
+14.18 (19.03%)
Jul 22, 2026, 4:00 PM EDT - Market closed
Arrowhead Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Reiterates $100 → $120 | Buy | Reiterates | $100 → $120 | +35.29% | Jul 23, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $110 → $126 | Buy | Reiterates | $110 → $126 | +42.05% | Jul 23, 2026 |
| Chardan Capital | Chardan Capital | Buy Maintains $90 → $115 | Buy | Maintains | $90 → $115 | +29.65% | Jul 22, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $100 | Buy | Reiterates | $100 | +12.74% | Jul 22, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $95 | Buy | Maintains | $95 | +7.10% | Jul 22, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Initiates $98 | Buy | Initiates | $98 | +10.48% | Jul 14, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 30, 2026 |
| Bernstein | Bernstein | Hold Reiterates $35 → $46 | Hold | Reiterates | $35 → $46 | -48.14% | May 13, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.